Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
hahaha anyone taking this board seriously with the who has credibility and who trumps who, thinking they are making friends here with their anonymous buddies,
planning his or her life around this message board because they do not have any other life job friends, or hobby is a pathetic loser such as yourself and that Flipflop44 or whatever.
I dont give a flying rat's ass fack about this dumb shit board, and dont post here too much because I actually do have a real life with businesses to run. Blew my credibility give me a fucking break what a pathetic nerdy moron
all incredibly wealthy. All legal bills are for all defendants' peanuts
nope I guarantee you I have not passed up on oiling bikini models on more than one occasion
You are absolutely right. The claim here that all cancer treatments, FDA-approved or not, are failed drugs because its not DCVAX is completely insane.
Blind fanatics
sure click on the link https://investorshub.advfn.com/boards/replies.aspx?msg=173765065
take the mouse from your mom's computer and move the mouse pointer on your screen (so not the actual mouse in your hand but the one on the screen) to the link (the link is in blue in the post). Click the right button on the mouse in your hand to open the link. Then reread the post. If you dont understand these instructions ask a caregiver to help you.
You are confusing. One day you claim Advent is an inevitable entwined undistinguishable part of NWBO aka the same company and the next post (as the one Im responding to now) you claim Advent is a disposable completely different nothing todo with NWBO CDMO which the acquiring big pharma could do without...
Make up your mind
well Immunomedics did not have any sales either. I do believe its about market revenue potential is what a large pharma would be paying for. Immunomedics was novel as well, at the time when they were bought as well.
well since they have not reported any update on Flaskworks I do believe that there is nothing to update us with, Therefor I think they will need a lot more engineers to get the job done. No one can say what the hold-up is until NWBO tells us.
sure they have agreements with third parties. But to then claim that these researchers and scientists working for and paid by those third parties are employed by NWBO is one of the most sycophant and kool-aid excuses I have ever heard when it comes to NWBO.
My companies have many agreements with other companies, can I now claim that those third-party employees are staffed by my company? The level of reality denial here is immense.
The point is of course nWBO is not going concern it is preparing to be bought after approval which is great.
false stament after false stament
Not true, NWBO has partnerships with UCLA, Cambridge University, and multiple other research centers
WRONG Absurd to claim that researchers and scientists staffed and paid by third parties such as UCLA are actually and secretly NWBO employees. Why now not claim that all Merck employees are actually and secretly NWBO staff? Come on do it claim that lol. Your Kool-aid must have been extra spicy with some very forbidden ingredients. NWBO does NOT employ any scientists or researchers like a going concern biotech company would
Not true, https://stockanalysis.com/stocks/nwbo/statistics/ NWBO employees (22) as of Feb 2nd, 2024.
WRONG According to NWBO's OWN LinkedIn page, NWBO employs 16 staff which is a decrease of 4 people in a year.
https://www.linkedin.com/company/northwest-biotherapeutics/people/ But you would of course ignore that and refer to your own self-created page as a source laughable
Not true, LP is more than capable to lead NWBO.
WRONG Your claim that Linda Powers is a certified CFO https://edu.berkeleyme.com/course/certified-cfo/ is one of your other outright LIES. Twisting what I said are you know. I said "NWBO does not have a certified CFO needed to manage the hundreds of millions that large pharma is supposed to invest for the joint trials"
Not true, sales support is the last stage in the product development process.
WRONG. When clear in sight of drug approval, as with NWBO, the biotech that plans to sell the soon-to-be-approved drug, should start putting together a sales support team 1.5 years before drug appraisal. You have no idea what you are talking about. There is not a hint of any of that with NWBO. I can see you have no understanding of biotech drug development
Not true, the Flaskworks "EDEN" unit is the last of three phases of the Flaskworks product and has been extensively tested and no need for further development
Wrong. There are 4 milestones to be paid by NWBO to former Flaskworks. The first has been paid. Crickets on the rest, and as stock payouts they are a mandatory disclosure. At the 2022 ASM (where did that 2023 ASM go anyway?) LP said how they were testing various very different processes with Eden. That should be a clue that it could not just reproduce the existing process. And further they were to select a version to proceed forward on last year. Until we get a clear PR on this from NWBO not much or no progress has been made on Eden .
As I have said.
NWBO is not going concern. NWBO is a shell company only holding IP and patents, therefor there is only one conclusion here that can be made which is:
After DCVAXL has been UK-approved NWBO will be bought for what I think is around 20 billion USD
NWBO does not employ any researchers to further develop DCVAX,
The CTO lives in Europe
NWBO staff diminished from 20 to 16 people
NWBO does not have a certified CFO needed to manage the hundreds of millions that large pharma is supposed to invest for the joint trials
NWBO does NOT have any sales supporting DCVAXL after DCVAXL is approved in the UK this year.
NWBO has stopped developing Flaskworks.
DCVAXL for pediatrics has not started
No new SAP/SPA for new trials have been submitted to the FDA
NWBO is not going concern. NWBO is a shell company only holding IP and patents, therefor there is only one conclusion here that can be made which is:
After DCVAXL has been UK-approved NWBO will be bought for what I think is around 20 billion USD. I know you take the opposite of that and think DCVAXL will not be approved, you will be proven wrong it will get approved.
I noticed one NWBO post you have a bearish sign added to your post (which is the most in line with you being an NWBO short) and the next a NWBO bullish (BS because you are a true NWBO short)
You sure are a borderline schizo. Again double dose your meds, schizo.
Keep dreaming Linda and Toucan will never give back Advent.
dude why would you even bother? The cat is out of the bag let me laugh in your face in a few months after DCVAXL is approved in the UK
CEO DaveDennis would have made Advent Ltd an NWBO subsidiary as it should have been and is fair to NWBO shareholders since they financed it. And even if CEO DaveDennis would be that egoistic to have the CDMO owned for free by Toucan then at least by now I would have sold 25% of Advent to a Private Equity partner to stop the endless NWBO dilution to finance Advent. CEO DaveDennis would have been a much better CEO to NWBO shareholders than that egoistic grifting self-dealing Powers
The whole MAA prep has nothing to do with it
You really should read up on how businesses are or should be run.
its absurd and illegitimate NWBO paying the salaries of 77 staff working at Advent a Toucan subsidiary yes contractors
well NWBO submitted a request for approval in the UK, so after the UK has approved, which it will, then you can eat your words.
you are absolutely right. That is why I would advise anyone to only invest in nonrevenue biotech that has already submitted a request for approval.
Better yet to not invest in biotech at all :)
I believe you have made a wise decision. I was invested in Anavex for 5 years. Bought at 6.2 on average didn't sell at 20+ then after it dropped to $8 and bounced back to $11 I sold after their messy unclear AD results.
Perhaps Anavex one day will have an approved drug for a (mental) condition and perhaps they will not But to me, Anavex starts to look like one of those biotechs with a drug looking for a (mental) condition to treat, which is never a good thing and triggered me to sell.
Kite Pharma had the same problem, too low valuation before they could be bought by a large pharma. So their M&A broker hired a PR pumping firm that started rumors of Kite being acquired which promoted the SP x3. After that Gliead was able to buy Kite
a lot of dumbasses on this board refusing to acknowledge something very uncomfortable called reality.
The Stock price is getting pounded because management dilutes the living crap out of the stock. Saying that makes you a short. Laughable.
somehow with your posts, I never can make it further than the first sentence where the BS is already pilehigh. Complete and other rubbish
are you really that dumb. I guess you are
we need whales to buy in and NWBO to stop diluting the living crap out of the stock. The formal isn't gonna happen at the OTC and the latter is not going to happen with Linda Powers refusing to make a non-dilutive deal to finance Advent a Toucan subsidiary with (for example) a private equity partner. With a private equity partner Linda Powers and Toucan would have to, God forbid, give up on a small portion of Advent. So they rather keep diluting us to finance Advent in an illegitimate manner.
If you coherently rephase yourself I may reply, right now I have no freaking clue what the heck you are rambling about
agreed yes to each their own. The problem that I do have with these stratosphere fantasy speculations that is food for bears and shorts
The idea that Merck is investing in production capacity now for a future deal that they may or may not enter in with NWBO in the future to produce DCVAX(L) without actually having entered into a deal with NWBO (which would be material and should have been disclosed) is ludicrous. These kinds of absurd claims (also the NWBO Apple valuation) will only help bears and shorts to ridicule longs as they have done with great success here.